+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Respiratory Inhalers Market Research Report by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, and Nebulizer), Age Group, Mode, Disease Indication, End-Use, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 246 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5666492
UP TO OFF until Mar 31st 2023
The Global Respiratory Inhalers Market size was estimated at USD 2,717.37 million in 2022, USD 2,967.32 million in 2023, and is projected to grow at a CAGR of 9.67% to reach USD 5,689.77 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Respiratory Inhalers Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Respiratory Inhalers Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Respiratory Inhalers Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Respiratory Inhalers Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Respiratory Inhalers Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market is studied across Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer, and Soft Mist Inhalers.
  • Based on Age Group, the market is studied across Adults and Pediatric.
  • Based on Mode, the market is studied across Digitally Operated Devices and Manually Operated Devices.
  • Based on Disease Indication, the market is studied across Asthma, Chronic Obstructive Pulmonary Disease, and Pulmonary Arterial Hypertension.
  • Based on End-Use, the market is studied across Clinics & Hospitals, Pharmacies, and Respiratory Care Center.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Respiratory Inhalers Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Respiratory Inhalers Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Respiratory Inhalers Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Respiratory Inhalers Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Inhalers Market, including AstraZeneca PLC, Beximco Pharmaceuticals Ltd., C.H. Boehringer Sohn Ko. KG, Cadila Healthcare Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, GlaxoSmithKline PLC, Heltman Medikal A.S., Koninklijke Philips N.V., Lupin Limited, Merck & Co., Inc., Microlife Corporation, Novartis AG, Opko Health, Inc., Rossmax International Ltd., and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Respiratory Inhalers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Inhalers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Inhalers Market?
4. What is the competitive strategic window for opportunities in the Global Respiratory Inhalers Market?
5. What are the technology trends and regulatory frameworks in the Global Respiratory Inhalers Market?
6. What is the market share of the leading vendors in the Global Respiratory Inhalers Market?
7. What modes and strategic moves are considered suitable for entering the Global Respiratory Inhalers Market?
Frequently Asked Questions about the Global Respiratory Inhalers Market

What is the estimated value of the Global Respiratory Inhalers Market?

The Global Respiratory Inhalers Market was estimated to be valued at $2717.37 Million in 2022.

What is the growth rate of the Global Respiratory Inhalers Market?

The growth rate of the Global Respiratory Inhalers Market is 9.6%, with an estimated value of $5689.77 Million by 2030.

What is the forecasted size of the Global Respiratory Inhalers Market?

The Global Respiratory Inhalers Market is estimated to be worth $5689.77 Million by 2030.

Who are the key companies in the Global Respiratory Inhalers Market?

Key companies in the Global Respiratory Inhalers Market include AstraZeneca PLC, Beximco Pharmaceuticals Ltd., C.H. Boehringer Sohn Ko. KG, Cadila Healthcare Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, GlaxoSmithKline PLC, Heltman Medikal A.S. and Lupin Limited.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in air pollution rate worldwide and occurrence of respiratory disorders
5.1.1.2. Increasing consumer awareness of pulmonary disorders
5.1.1.3. Growing government focus on improving asthma care
5.1.2. Restraints
5.1.2.1. Stringent regulations for inhaler approvals by the government
5.1.3. Opportunities
5.1.3.1. Introduction of innovative smart inhalers
5.1.3.2. Development of effective inhaler medication formulations
5.1.4. Challenges
5.1.4.1. Incorrect usage and operational issues in inhalers
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Respiratory Inhalers Market, by Product Type
6.1. Introduction
6.2. Dry Powder Inhaler
6.3. Metered Dose Inhaler
6.4. Nebulizer
6.5. Soft Mist Inhalers

7. Respiratory Inhalers Market, by Age Group
7.1. Introduction
7.2. Adults
7.3. Pediatric

8. Respiratory Inhalers Market, by Mode
8.1. Introduction
8.2. Digitally Operated Devices
8.3. Manually Operated Devices

9. Respiratory Inhalers Market, by Disease Indication
9.1. Introduction
9.2. Asthma
9.3. Chronic Obstructive Pulmonary Disease
9.4. Pulmonary Arterial Hypertension

10. Respiratory Inhalers Market, by End-Use
10.1. Introduction
10.2. Clinics & Hospitals
10.3. Pharmacies
10.4. Respiratory Care Center

11. Americas Respiratory Inhalers Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Respiratory Inhalers Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Respiratory Inhalers Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Product Portfolio Analysis, By Key Player
14.5. Competitive Scenario
14.5.1. Merger & Acquisition
14.5.2. Agreement, Collaboration, & Partnership
14.5.3. New Product Launch & Enhancement
14.5.4. Investment & Funding
14.5.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. AstraZeneca PLC
15.2. Beximco Pharmaceuticals Ltd.
15.3. C.H. Boehringer Sohn Ko. KG
15.4. Cadila Healthcare Ltd.
15.5. Chiesi Farmaceutici S.p.A.
15.6. Cipla Limited
15.7. GlaxoSmithKline PLC
15.8. Heltman Medikal A.S.
15.9. Koninklijke Philips N.V.
15.10. Lupin Limited
15.11. Merck & Co., Inc.
15.12. Microlife Corporation
15.13. Novartis AG
15.14. Opko Health, Inc.
15.15. Rossmax International Ltd.
15.16. Teva Pharmaceutical Industries Ltd.

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL RESPIRATORY INHALERS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL RESPIRATORY INHALERS MARKET DYNAMICS
FIGURE 11. GLOBAL RESPIRATORY INHALERS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT TYPE, 2030
FIGURE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2022 VS 2030 (%)
FIGURE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY AGE GROUP, 2030
FIGURE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2022 VS 2030 (%)
FIGURE 25. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 26. GLOBAL RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY MODE, 2030
FIGURE 27. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DIGITALLY OPERATED DEVICES, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MANUALLY OPERATED DEVICES, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2030 (%)
FIGURE 30. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 31. GLOBAL RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASE INDICATION, 2030
FIGURE 32. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, 2018-2030 (USD MILLION)
FIGURE 35. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 36. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 37. GLOBAL RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 38. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS & HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 39. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
FIGURE 40. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESPIRATORY CARE CENTER, 2018-2030 (USD MILLION)
FIGURE 41. AMERICAS RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 43. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 44. AMERICAS RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 45. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. BRAZIL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. CANADA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. MEXICO RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 51. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 52. UNITED STATES RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 53. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 55. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 56. ASIA-PACIFIC RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 57. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. CHINA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. INDIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. INDONESIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. JAPAN RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. TAIWAN RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. THAILAND RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. VIETNAM RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 73. DENMARK RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. EGYPT RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. FINLAND RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. FRANCE RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. GERMANY RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. ISRAEL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. ITALY RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. NIGERIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. NORWAY RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. POLAND RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. QATAR RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. RUSSIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. SPAIN RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. SWEDEN RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. TURKEY RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 92. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 93. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 94. GLOBAL RESPIRATORY INHALERS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 95. GLOBAL RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 96. GLOBAL RESPIRATORY INHALERS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL RESPIRATORY INHALERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DIGITALLY OPERATED DEVICES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DIGITALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DIGITALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MANUALLY OPERATED DEVICES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MANUALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MANUALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE , BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE , BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS & HOSPITALS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESPIRATORY CARE CENTER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESPIRATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESPIRATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. CANADA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. CANADA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 76. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. CHINA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 105. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. CHINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. CHINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 108. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 109. CHINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. INDIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 111. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. INDIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. INDIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 114. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 115. INDIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. JAPAN RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 123. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 126. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 127. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 158. THAILAND RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 159. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 162. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 163. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. DENMARK RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 178. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 181. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 183. EGYPT RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 184. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 186. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 187. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 188. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. FINLAND RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. FRANCE RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 196. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 198. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 200. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 201. GERMANY RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 202. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 205. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 206. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 213. ITALY RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 214. ITALY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. ITALY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 216. ITALY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 217. ITALY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 218. ITALY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 225. NIGERIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 226. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 228. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 229. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 231. NORWAY RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 232. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 234. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 235. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 236. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 237. POLAND RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 238. POLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. POLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. POLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 241. POLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 242. POLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 243. QATAR RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 244. QATAR RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. QATAR RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. QATAR RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 247. QATAR RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 248. QATAR RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 267. SPAIN RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 268. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 271. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 272. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 279. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 280. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 282. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 283. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 285. TURKEY RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 286. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 289. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 290. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 298. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 300. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 302. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 303. GLOBAL RESPIRATORY INHALERS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 304. GLOBAL RESPIRATORY INHALERS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 305. GLOBAL RESPIRATORY INHALERS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 306. GLOBAL RESPIRATORY INHALERS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 307. GLOBAL RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 308. GLOBAL RESPIRATORY INHALERS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 309. GLOBAL RESPIRATORY INHALERS MARKET MERGER & ACQUISITION
TABLE 310. GLOBAL RESPIRATORY INHALERS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 311. GLOBAL RESPIRATORY INHALERS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 312. GLOBAL RESPIRATORY INHALERS MARKET INVESTMENT & FUNDING
TABLE 313. GLOBAL RESPIRATORY INHALERS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 314. GLOBAL RESPIRATORY INHALERS MARKET: LICENSE & PRICING

Companies Mentioned

  • AstraZeneca PLC
  • Beximco Pharmaceuticals Ltd.
  • C.H. Boehringer Sohn Ko. KG
  • Cadila Healthcare Ltd.
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • GlaxoSmithKline PLC
  • Heltman Medikal A.S.
  • Koninklijke Philips N.V.
  • Lupin Limited
  • Merck & Co., Inc.
  • Microlife Corporation
  • Novartis AG
  • Opko Health, Inc.
  • Rossmax International Ltd.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...